skip to Main Content


Quality, Speed & Performance – Key Attributes to Canada’s Oncology Clinical Trial Future


An interview with Karen Arts of the Ontario Institute for Cancer Research

Canada boasts several centers of excellence with a group of internationally renowned investigators that are at the forefront of oncology clinical research. Many of these centers are highly skilled in early phase work and are highly motivated to help fix a system that is in dire need of repair.

Listen as Karen Arts, Director of Business Development at the OICR and chair of the board of directors for the Network of Networks (N2), talks about the steps Canadian organizations have taken to foster collaboration among stakeholder groups, while improving infrastructure and processes to enhance Canada’s clinical research capability and capacity.

Listen To Interview

Sign up to
Canadian Oncology
Trial News

  • This field is for validation purposes and should be left unchanged.
Back To Top